14,486 Shares in Astera Labs, Inc. $ALAB Acquired by Greenwood Capital Associates LLC

Greenwood Capital Associates LLC purchased a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the 1st quarter, HoldingsChannel.com reports. The institutional investor purchased 14,486 shares of the company’s stock, valued at approximately $1,588,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in ALAB. Atreides Management LP increased its stake in Astera Labs by 2,496.6% in the fourth quarter. Atreides Management LP now owns 1,611,194 shares of the company’s stock valued at $268,038,000 after purchasing an additional 1,549,144 shares during the period. Amundi boosted its stake in shares of Astera Labs by 1,298.6% during the third quarter. Amundi now owns 1,421,263 shares of the company’s stock worth $278,283,000 after buying an additional 1,319,643 shares during the period. BNP Paribas Financial Markets boosted its stake in shares of Astera Labs by 577.3% during the third quarter. BNP Paribas Financial Markets now owns 1,127,340 shares of the company’s stock worth $220,733,000 after buying an additional 960,899 shares during the period. Artisan Partners Limited Partnership purchased a new position in shares of Astera Labs during the fourth quarter worth about $148,980,000. Finally, Goldman Sachs Group Inc. grew its holdings in shares of Astera Labs by 189.0% during the fourth quarter. Goldman Sachs Group Inc. now owns 1,312,927 shares of the company’s stock worth $218,419,000 after buying an additional 858,693 shares during the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Stock Up 2.7%

NASDAQ ALAB opened at $393.16 on Thursday. The stock has a market capitalization of $67.39 billion, a P/E ratio of 265.65, a P/E/G ratio of 4.39 and a beta of 3.66. Astera Labs, Inc. has a 52-week low of $88.18 and a 52-week high of $499.48. The firm has a 50-day moving average price of $326.75 and a 200 day moving average price of $211.47.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The company had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. During the same quarter in the previous year, the company earned $0.33 EPS. The firm’s revenue for the quarter was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, equities research analysts expect that Astera Labs, Inc. will post 1.84 earnings per share for the current fiscal year.

Insider Transactions at Astera Labs

In other news, Director Manuel Alba sold 136,974 shares of the firm’s stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $442.01, for a total value of $60,543,877.74. Following the completion of the sale, the director directly owned 1,287,524 shares of the company’s stock, valued at $569,098,483.24. This trade represents a 9.62% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 400,000 shares of Astera Labs stock in a transaction that occurred on Thursday, May 21st. The shares were sold at an average price of $290.30, for a total value of $116,120,000.00. Following the completion of the sale, the chief operating officer owned 5,064,213 shares in the company, valued at approximately $1,470,141,033.90. This trade represents a 7.32% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 2,164,441 shares of company stock valued at $526,198,280. Corporate insiders own 10.40% of the company’s stock.

Analysts Set New Price Targets

Several analysts have commented on the company. Royal Bank Of Canada upped their price objective on Astera Labs from $250.00 to $270.00 and gave the company an “outperform” rating in a research note on Wednesday, May 6th. JPMorgan Chase & Co. boosted their target price on Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a report on Wednesday, May 6th. TD Cowen boosted their target price on Astera Labs from $140.00 to $225.00 and gave the company a “hold” rating in a report on Wednesday, May 6th. Rothschild & Co Redburn started coverage on Astera Labs in a research note on Friday, May 1st. They set a “neutral” rating and a $153.00 price target for the company. Finally, Barclays increased their price target on Astera Labs from $165.00 to $200.00 and gave the stock an “equal weight” rating in a report on Thursday, May 7th. Twelve investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $265.75.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.